BioSig Technologies Balance Sheet Health
Financial Health criteria checks 1/6
BioSig Technologies has a total shareholder equity of $-283.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.4M and $1.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$615.00k |
| Equity | -US$283.00k |
| Total liabilities | US$1.70m |
| Total assets | US$1.42m |
Recent financial health updates
Recent updates
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now
Dec 12
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
Dec 14BioSig in acquisition pact with San Antonio Hospital for cardiac signal system
Oct 07BioSig: No Changes To Hold Thesis Following Q2 Earnings
Sep 08BioSig signs purchase deal with Kansas City's Overland Park Regional hospital
Jul 07BioSig: PURE EP Economics Trade Exhausted
Jun 14Financial Position Analysis
Short Term Liabilities: BSGM has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: BSGM has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: BSGM is debt free.
Reducing Debt: BSGM's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BSGM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BSGM has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.2% each year